Everolimus May Reduce CMV Risk
DENVER—Use of everolimus (EVR) rather than mycophenolic acid (MPA) in renal transplant recipients may significant decrease the risk for cytomegalovirus events, according to a study.
Renal Week 2010
Artery Size and Diabetes Predict AVF Patency
DENVER—Artery size is the only predictor of both primary and secondary patency in arteriovenous fistula (AVF) placement in hemodialysis (HD) patients, researchers reported at Renal Week 2010. The presence of diabetes predicted primary patency only.
CAB Surgery May Be Superior to Stents Long Term
DENVER—Drug-eluting stents (DES) provide the best short-term survival for dialysis patients who require coronary revascularization, but coronary artery bypass (CAB) surgery may offer better long-term survival, researchers reported at the 2010 Renal Week conference.
Novel Binder Lowers Phosphorus, LDL Cholesterol
An investigational calcium-free phosphate binder called colestilan is safe and effective for controlling phosphorus in dialysis patients, and it has no impact on calcium levels, researchers reported.
Lipid Lowering Reduces Cardiovascular Risk in CKD Patients
Cholesterol-lowering treatment with a combination of ezetimibe and simvastatin significantly decreases the likelihood of major atherosclerotic events in patients with chronic kidney disease (CKD), according to the findings of the five-year Study of Heart and Renal Protection (SHARP) trial.
Investigational Drug May Reverse CKD
DENVER—Recent trial data suggest that an investigational agent called bardoxolone methyl may improve renal function in type 2 diabetics with moderate to severe chronic kidney disease (CKD).
Lowering Cholesterol Reduces CV Event Risk in CKD Patients
DENVER—Cholesterol-lowering treatment with a combination of ezetimibe and simvastatin significantly decreases the likelihood of major atherosclerotic events in patients with chronic kidney disease (CKD), according to the findings of the five-year Study of Heart and Renal Protection (SHARP) trial.
Worsening Kidney Disease in Blacks Linked to Gene Variant
A common gene variant appears to be associated with a sharply increased risk of progressive kidney disease in African Americans (AAs) with hypertensive nephrosclerosis, according to a study presented at Renal Week 2010 in Denver.
Target Higher Hb May Be Renoprotective in Tx Patients
Researchers at Renal Week 2010 in Denver have reported on what they believe is the first prospective, randomized study to show that targeting a serum hemoglobin (Hb) level of 13 g/dL or higher has a renoprotective effect in kidney transplant patients.
H1N1 Vaccine May Not Protect Most Kidney Transplant Recipients
Most renal transplant recipients may not benefit from being vaccinated against the H1N1 influenza virus, according to a new German study presented at Renal Week 2010 in Denver.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Renal Week 2010 General News
Loading... 
Loading...